Use of olanzapine to treat agitation in traumatic brain injury: study protocol for a randomised controlled trial
Abstract Background Agitation is common in the early stages of recovery from traumatic brain injury (TBI), when patients are in post-traumatic amnesia (PTA). Agitation is associated with risk of harm to patients and caregivers. Recent guidelines recommend that agitation during PTA is managed using e...
Main Authors: | Ruby K Phyland, Adam McKay, John Olver, Mark Walterfang, Malcolm Hopwood, Amelia J Hicks, Duncan Mortimer, Jennie L Ponsford |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-07-01
|
Series: | Trials |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s13063-020-04553-2 |
Similar Items
-
The Psychopharmacology of Agitation: Consensus Statement of the American Association for Emergency Psychiatry Project BETA Psychopharmacology Workgroup
by: Michael P. Wilson, et al.
Published: (2012-04-01) -
Intramuscular olanzapine versus intramuscular haloperidol plus lorazepam for the treatment of acute schizophrenia with agitation: An open-label, randomized controlled trial
by: Charles Lung-Cheng Huang, et al.
Published: (2015-05-01) -
Effectiveness and safety of oral olanzapine treatment transitioned from rapid-acting intramuscular olanzapine for agitation associated with schizophrenia
by: Katagiri H, et al.
Published: (2018-04-01) -
Agitation Following Severe Traumatic Brain Injury Is a Clinical Sign of Recovery of Consciousness
by: Zhe Wang, et al.
Published: (2021-04-01) -
Olanzapine-induced skin eruptions
by: Nishtha Chawla, et al.
Published: (2017-01-01)